Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
29.05.24
/
50%
€46.00
Target price
29.05.25
€68.37
Performance (%)
33.70%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. The BUY prediction by The_Goldman_Sachs_Gr for Insmed Inc. saw massive gains of 33.70%. The_Goldman_Sachs_Gr has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 2.326% | 2.326% | 146.154% |
| iShares Core DAX® | 2.705% | -1.771% | 22.133% |
| iShares Nasdaq 100 | 4.127% | -1.874% | 11.324% |
| iShares Nikkei 225® | 1.944% | -3.187% | 15.692% |
| iShares S&P 500 | 2.919% | -0.149% | 4.642% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten